New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2014
08:03 EDTANIPANI Pharmaceuticals enters development agreement with Sterling Pharmaceutical
ANI Pharmaceuticals announced that it has entered into a fee-for-service development agreement for a generic drug product with Sterling Pharmaceutical Services. The product will be developed by Sterling and transferred into ANI's facilities for commercial manufacture and marketing. The current annual market for this product is $60M, according to IMS Health.
News For ANIP From The Last 14 Days
Check below for free stories on ANIP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2014
07:38 EDTANIPANI Pharmaceuticals likely rebounding on price hike, says Oppenheimer
Subscribe for More Information
April 15, 2014
08:41 EDTANIPANI Pharmaceuticals fundamentals appear on track, says Roth Capital
After ANI's stock came under considerable pressure, Roth Capital spoke with the company's management and thinks the company's fundamentals remain on track. The firm believes that the company's revenue and EPS could beat expectations, and it reiterates a Buy rating on the stock.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use